25-27 September 2018
Tumor Models Shanghai is the only industry-focused preclinical oncology meeting in Asia, where we will be uniting the thought-leaders and decision-makers in pharma and biotech to explore the most recent developments in the field.
As we see more and more oncology products failing in the clinic there needs to be a revolution in the way we conduct our preclinical and translational research. Tumor Models Shanghai is the platform that will bring together experts from Pharma and Biotech from across Asia to discuss the vital challenges currently facing the industry.
By joining us you will get access to insight into the in vivo models that are driving research forward. Including, information on the newest in vivo models, deep dives into the prediction and overcoming of resistance mechanisms, the optimisation of model and target selection rationale; and more.
Innovent Biologics who will be sharing how they overcame a novel resistance mechanism
Crown Bioscience, will be sharing the latest updates their MuPrime Platform for Immuno-Oncology discovery
Hear the way that EpimAb has leveraged information from throughout their preclinical phase to better inform their clinical trial decisions
Gain an understanding of the innovative new Humanized Mouse platforms are that the The Jackson Laboratory have developed
As well as others from Abxign, Zai Labs, ASLAN Pharma, Oncologie International, Elpiscience, Duke-NUS